These data support the hypothesis that, in contrast to MYB-TR, the MYB::PLEKHO1 fusion may be sufficient to induce leukemia as a single event because it bypasses the G1/S checkpoint and does not induce strong expression of p16INK4A and p19ARF. The gene discussed is CDKN2A; the disease is leukemia.